JACLYN GUTIERREZ
Family Nurse Practitioner · AUSTIN, TX
Individual Active NPI 1578288189
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 630 | 220,816 | $13,871,707 | $3,466,625 | $2,755,524 |
| 2023 | 582 | 154,001 | $12,626,809 | $3,159,497 | $2,509,365 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 73,850 | $1 | $1 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 28,980 | $11 | $9 |
| J0897 | Injection, denosumab, 1 mg | 14,940 | $26 | $21 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 11,250 | $1 | $1 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 9,900 | $22 | $17 |
| J2182 | Injection, mepolizumab, 1 mg | 8,500 | $29 | $23 |
| J1756 | Injection, iron sucrose, 1 mg | 7,400 | $0 | $0 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 6,300 | $18 | $14 |
| J2357 | Injection, omalizumab, 5 mg | 4,695 | $38 | $30 |
| J3245 | Injection, tildrakizumab, 1 mg | 2,800 | $135 | $108 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,110 | $29 | $23 |
| 96372 | Injection of drug or substance under skin or into muscle | 826 | $12 | $10 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 1095990 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Texas
- NPI 1508783036
- NPI 1093479487
- NPI 1922597699
- NPI 1528524857
- NPI 1518377498
- NPI 1578926440
- NPI 1134842321
- NPI 1992053797
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.